Sourcing, manufacturing and supply chain
UCB is committed to fostering ethical and responsible practices in our supply chain, while ensuring that our sourcing, manufacturing and supplier relationships and partnerships deliver growth and competitive advantages.
A comprehensive global network ensures the adequate supply of quality medical products that are important for people living with severe chronic diseases. The supply chain is a functionally organized entity with strong centralized governance and with direct links with UCB’s departments, related product-franchises and with commercial geographies.
The key value in the manufacturing, supply and purchasing departments is an effective governance of the external network of suppliers, contract manufacturing organizations (CMO), contract laboratories, carriers, third-party logistics and commercial distributors, whereby risk management is a major component.
Colleagues in the purchasing department operate in 20 countries overlooking 21 580 different suppliers, predominantly in eight countries, i.e., Belgium, China, Germany, Japan, Spain, Switzerland, U.K. and U.S.
The Supply Chain Security Council overlooks the responsible supply chain management and holds manufacturing and supply partners to high-quality standards. The Council reviews product and supply chain security and enforces UCB’s global anti-counterfeiting strategy to ensure the patient’s and public health. The cross-functional team is also responsible to detect, mitigate, address, and prevent risks originating from potential adulteration, theft, counterfeit or diversion of products that may threaten patient safety.
UCB applies similar standards for quality and effectiveness to technically complex formulations and specific packaging produced in our own global manufacturing and in our contract manufacturing organizations. The supply management involves adequate supply chain planning, inventory and transportation/delivery management, temperature control management, logistics service providers and logistics security, ensuring sound environmental health and safety conditions, dangerous goods compliance, and global trade management.
UCB signed the Science Based Targets initiatives, which implies Green House Gas (GHG) emission targets supporting the COP21 ambition (to maintain the increase of the global temperature by the end of the century to well below 2°C) will be defined for our entire value chain, thus including the external network of suppliers, contract manufacturing organizations (CMO), contract laboratories, carriers, third-party logistics and commercial distributors.
Through the serialization program an additional control and authentication across the supply chain is guaranteed while our trade programs manage partnerships with our distributors to help protect our medicines and to ensure integrity of those medicines up to the patient.